A combined treatment with tacrolimus (FK506) and recombinant tissue plasminogen activator for thrombotic focal cerebral ischemia in rats: increased neuroprotective efficacy and extended therapeutic time window.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples